- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.45 Å
- Oligo State
- hetero-4-4-4-mer
- Ligands
- 4 x NAG- NAG- BMA- MAN- MAN- MAN- MAN- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 4 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 4 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x CA: CALCIUM ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Stadlbauer, D. et al., Broadly protective human antibodies that target the active site of influenza virus neuraminidase. Science (2019)
- Release Date
- 2019-10-23
- Peptides
- Neuraminidase: ADGJ
1G04 Fab kappa light chain: BEHK
1G04 Fab IgG1 heavy chain: CFIL - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BD
BG
BJ
BB
CE
CH
CK
CC
DF
DI
DL
D